Potential treatment for Chikungunya discovered by Vivalis and A*STAR’s SIgN
Singapore – Nantes (France) — February 15, 2011 (SGT) – The Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS (NYSE Euronext: VLS), a French biopharmaceutical company, annou…